Gait Disorders, Neurologic Clinical Trial
Official title:
A Phase II, Double-Blind, Placebo-Controlled Randomized Crossover Study to Assess the Clinical Benefit and Safety of Droxidopa in the Treatment of Freezing of Gait Symptoms in Patients With Parkinson's Disease
Freezing of Gait (FoG) is a class of symptoms that occur in Parkinson's patients. Also
called motor blocks, FoG is characterized by a sudden inability to move the lower
extremities which usually lasts less than 10 seconds. The exact pathophysiology of FoG is
poorly understood, but treatment with levodopa appears to improve FoG observed in the
off-state. As Parkinson's patients progress in severity, FoG in the on-state can increase in
frequency and appears to be resistant to dopaminergic therapies. There is additional
evidence that norepinephrine as well as dopaminergic systems may be involved in FoG.
Droxidopa has has been approved for use in Japan since 1989 for treatment of frozen gait or
dizziness associated with Parkinson's Disease. This study is to further explore the safety
and efficacy of droxidopa in this indication.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03593512 -
Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy
|
N/A | |
Completed |
NCT04117737 -
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
|
N/A | |
Recruiting |
NCT04265482 -
Community-based Cohort of Functional Decline in Subjective Cognitive Complaint Elderly
|
||
Completed |
NCT03192046 -
Bracing for Walking in Parkinson's Disease
|
N/A | |
Terminated |
NCT01678547 -
Robot Walking Rehabilitation in Stroke Patients
|
N/A | |
Recruiting |
NCT05510739 -
Support for Physical Activity in Everyday Life With Parkinson's Disease
|
N/A | |
Recruiting |
NCT05417399 -
Influence of Hawthorne Effect and Dual-tasks on Gait in CP
|
||
Completed |
NCT05683925 -
Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Gait Characteristics in Parkinson's Disease
|
N/A | |
Recruiting |
NCT05801874 -
Gait and Posture Analysis in Hemiparetic Patients Through Optoelectronic Systems, "Smart" Tools and Clinical Evaluation
|
||
Recruiting |
NCT05110053 -
Spinal Cord sTimulation thEraPy for Parkinson's Disease Patients With Gait Problems
|
Phase 1 | |
Recruiting |
NCT04137146 -
SNS for Treatment of PD Gait Disorder
|
N/A | |
Terminated |
NCT05622786 -
Effect of High-Intensity Gait Training Using a Treadmill on Locomotion Recovery in Traumatic Brain Injury Patients
|
N/A | |
Recruiting |
NCT04855825 -
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
|
N/A | |
Recruiting |
NCT05022147 -
Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease
|
Phase 1 | |
Completed |
NCT04266743 -
FeetMe® Monitor: Alternative for the Evaluation of Gait Speed After Stroke
|
N/A | |
Completed |
NCT04622657 -
Validity Reliability of The Dubousset Functional Test in Parkinson Disease
|
N/A | |
Completed |
NCT02356536 -
The Effect of a Wearable Cueing Device on Freezing of Gait in Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00914095 -
Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II)
|
Phase 4 | |
Completed |
NCT01108029 -
Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
|
Phase 4 | |
Completed |
NCT03314610 -
Effect of Need to Void on Parkinsonian Gait
|